Cardiac transplantation: the final therapeutic option for the treatment of heart failure

被引：15

作者：

Koerner, MM ^{[1
]}

Durand, JB ^{[1
]}

Lafuente, JA ^{[1
]}

Noon, GP ^{[1
]}

Torre-Amione, G ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

来源：

CURRENT OPINION IN CARDIOLOGY | 2000年 / 15卷 / 03期

关键词：

D O I：

10.1097/00001573-200005000-00010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery. (C) 2000 Lippincott Williams & Wilkins, Inc.

引用

页码：178 / 182

页数：5

共 50 条

[1] Is heart transplantation for primary cardiac sarcoma a useful therapeutic option?
Mazeucos, JMJ
Manso, RF
Cubero, JS
Ramos, JT
Domínguez, JFO
Rivera, LAP
REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (04): : 408 - 411
[2] The modulation of cardiac contractility: a therapeutic option for the patient with refractory heart failure
Cappannoli, Luigi
Scacciavillani, Roberto
Rocco, Erica
Perna, Francesco
Narducci, Maria Lucia
Gabrielli, Francesca Augusta
Vaccarella, Marcello
D'Amario, Domenico
Pelargonio, Gemma
Massetti, Massimo
Crea, Filippo
Aspromonte, Nadia
GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (03) : 212 - 220
[3] Cardiac resynchronisation treatment:: A treatment option for heart failure children with dilatative cardiomyopathy
Abdul-Khaliq, H.
Schuck, R.
Thiemig, D.
Rentzsch, A.
Yigitbasi, M.
Peters, B.
Froehlig, G.
Berger, F.
Lange, P. E.
CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (09) : 664 - 664
[4] HETEROTOPIC CARDIAC TRANSPLANTATION, A VALID THERAPEUTIC OPTION
Mugianesi, Oscar
Burgos, Claudio
Carrieri, Fabio
Sendra, Vicente
Palma, Jose Lodovico
Bargazzi, Gustavo
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2006, 35 (01): : 14 - 20
[5] Cardiac stem cells: A promising treatment option for heart failure (Review)
Zhao, Xiaohui
Huang, Lan
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (02) : 379 - 383
[6] A case report of cardiac contractility modulation therapy for heart failure treatment in patient with amyloidosis: is to be considered a valid therapeutic option?
Mattera, Agostino
Coscia, Vincenzo
Brignoli, Marcello
Fusco, Angela
Concilio, Claudia
Chianese, Raffaele
De Michele, Alfonso
Pariggiano, Ivana
Diana, Vincenzo
Viscusi, Miguel
Calabro, Paolo
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
[7] FOCUS ON FLOSEQUINAN - A NEW THERAPEUTIC OPTION FOR THE TREATMENT OF CONGESTIVE-HEART-FAILURE
KERTLAND, H
KLUGER, J
CHOW, MSS
HOSPITAL FORMULARY, 1992, 27 (10): : 1005 - &
[8] Therapeutic Potential of Cardiac Myosin Activators for the Treatment of Heart Failure
Jin, Yulan
Wu, Xiaoliang
Zhou, Xiangying
LATIN AMERICAN JOURNAL OF PHARMACY, 2024, 43 (02): : 345 - 350
[9] A case report of cardiac contractility modulation therapy for heart failure treatment in patient with amyloidosis: is to be considered a valid therapeutic option?
Mattera, Agostino
Coscia, Vincenzo
Brignoli, Marcello
Fusco, Angela
Concilio, Claudia
Chianese, Raffaele
De Michele, Alfonso
Pariggiano, Ivana
Diana, Vincenzo
Viscusi, Miguel
Calabro, Paolo
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
[10] Cardiac surgery late after heart transplantation: A safe and effective treatment option
Goerler, Heidi
Simon, Andre
Warnecke, Gregor
Meyer, Anna L.
Kuehn, Christian
Haverich, Axel
Strueber, Martin
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (02): : 433 - 439

← 1 2 3 4 5 →